(EVH) Evolent Health, Inc. Marketing Mix Research |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
(EVH) Evolent Health, Inc. Complete Analysis Pack
This Evolent Health, Inc. 4P's Marketing Mix Analysis explains the company’s product offerings, pricing approach, distribution channels, and promotional tactics in a concise, actionable format; the page includes a real preview/sample so you can evaluate style and content before buying. Purchase the full version to receive the complete, ready-to-use analysis.
Product
Evolent Health runs through two segments, Evolent Health Services and Clinical Solutions, so the product is a B2B healthcare services platform, not a consumer offering. The mix pairs administrative support with clinical management, helping payer and provider clients manage care workflows and costs. In its latest reported filings, this two-part model stays central to revenue and operating execution.
Identifi is Evolent Health, Inc.'s proprietary data platform, and it sits at the center of its population health model. It aggregates clinical and claims data to guide care workflows and improve patient engagement. By helping target the right members faster, it supports lower total care costs and more efficient management at scale.
Evolent Health Services’ population health management helps health plans track risk, close care gaps, and steer members to the right care. It combines financial and administrative support, analytics, reporting, and strategic leadership to lower total cost of care while improving outcomes. The model matters in a market where Medicare Advantage membership topped 33 million in 2025, pushing payers to manage quality and cost more tightly.
Specialty care management
Evolent Health, Inc.'s Specialty care management, through Clinical Solutions, manages high-cost specialty care, with a clear fit in oncology and cardiology. It helps payers and providers shift from fee-for-service to value-based care by tightening coordination, reducing avoidable variation, and linking care to outcomes.
- Focus: oncology and cardiology
- Model: value-based care support
- Goal: better outcomes, lower waste
US healthcare payers and providers
Evolent Health, Inc. serves healthcare payers and providers across the United States with enterprise tools built for complex care management, utilization management, and value-based care operations. The product blends services and software, so clients get workflow support plus analytics in one model.
That fit matters for large U.S. health systems, where Evolent reported $2.59 billion in revenue for fiscal 2024 and managed care arrangements tied to national scale. This positions the product as a high-touch, software-enabled service for enterprise buyers with heavy administrative and clinical needs.
- U.S. payer and provider focus
- Enterprise care operations use case
- Services plus software delivery model
Evolent Health's product is a B2B care-management stack for U.S. payers and providers, split across Evolent Health Services and Clinical Solutions. It blends services and software to manage utilization, close care gaps, and support value-based care.
Its core tools include Identifi, plus specialty care management in oncology and cardiology. Evolent Health reported $2.59 billion in revenue for fiscal 2024.
| Metric | Latest data |
|---|---|
| Model | Services + software |
| Focus | Payers, providers |
| Revenue | $2.59B FY2024 |
What is included in the product
Detailed Word Document
A concise, company-specific breakdown of Evolent Health, Inc.’s 4P marketing mix, grounded in real market positioning and strategic implications.
Editable Excel File
Summarizes Evolent Health’s 4Ps as a quick, decision-ready view that eases strategic review and team alignment.
Reference Sources
Provides a concise bibliography linking each Evolent Health claim to primary industry reports, SEC filings, and government datasets for fast, defensible due diligence.
Place
Evolent Health’s Arlington, Virginia headquarters is its primary base of operations and the hub for corporate, operational, and leadership functions. That single site anchors decisions across the business and keeps top management close to day-to-day execution. In 2025, this one headquarters served as the center for the company’s main control point.
Evolent Health, Inc. serves national healthcare organizations across the United States, not local retail buyers. Its market footprint is broad, enterprise-focused, and built around payers and provider groups that operate in multiple states. In 2024, Evolent reported $2.0 billion in revenue, showing the scale of its U.S. platform.
Evolent Health uses direct B2B delivery, selling into payer and provider organizations instead of consumers. This model fits complex, contracted deployments because the service is embedded inside client workflows and payer operations. Its latest filings show the business remains built around long-term, enterprise-level care management contracts, not retail channels.
Technology-enabled delivery
Evolent Health, Inc.’s delivery is mostly digital and service-based: Identifi supports remote data aggregation, analytics, and workflow coordination, so the model relies less on physical channels and more on software-led care management. In 2025, Evolent reported $1.9 billion in adjusted revenue, underscoring the scale of its tech-enabled delivery model.
- Remote data and workflow support
- Less reliance on physical distribution
- Digital services drive delivery
Embedded client operations
Evolent Health, Inc. embeds its solutions inside client workflows, so care programs run where health plans and providers already manage members and patients. That setup cuts handoffs, raises access, and makes day-to-day use simpler for customers. It also helps align clinical actions with the client’s own operating model.
- Built into client care operations
- Delivered in existing workflows
- Improves access and convenience
- Reduces operating friction
Evolent Health’s Place is U.S.-only and enterprise-based: its Arlington, Virginia headquarters steers national delivery to payer and provider clients. In 2025, the company reported $1.9 billion in adjusted revenue, showing the scale of its dispersed service footprint.
| Place factor | 2025 data |
|---|---|
| HQ | Arlington, Virginia |
| Market | United States |
| Adjusted revenue | $1.9 billion |
Get Your Copy
Evolent Health, Inc. Reference Sources
The preview shown here is the actual Evolent Health, Inc. 4P's Marketing Mix analysis you’ll receive instantly after purchase—comprehensive, editable, and ready to use with no surprises.
Promotion
Evolent Health sells directly to healthcare organizations, so the buying process stays enterprise-led and relationship driven. That fits long sales cycles and custom contracts, which matter in a business that reported about $2.5 billion in revenue in 2024 and serves large payer and provider accounts. One big deal can move the needle, so direct sales is the right promotion channel.
Evolent Health can use thought leadership in healthcare policy, value-based care, and specialty care to build awareness and show it can manage complex programs at scale. Its 2024 revenue was about $2.5 billion, so credible expertise can help protect and grow that base. Sharing clear clinical and admin insights also helps build trust with payer and provider leaders.
Evolent Health uses earnings releases, SEC filings, and investor presentations to explain strategy, operations, and financial performance. In 2025, these updates kept investors focused on execution, margin trends, and cash flow, while also strengthening the Company’s market image. It is a direct brand-building channel that helps shape how analysts and shareholders view Company Name.
Partnership messaging
Evolent Health, Inc. promotes partnerships around measurable value: better outcomes, sharper analytics, and lower client costs. In healthcare services sales, case studies and payer-client stories matter because buyers want proof that care can improve quality and reduce waste, not just a pitch. The message is simple: show the results.
- Focus on outcomes and cost reduction
- Use case stories as proof
- Lead with measurable client value
Industry presence
Evolent Health, Inc. uses healthcare conferences and professional forums to stay visible with payers, providers, and value-based care leaders. These events matter in specialty and population health because they build trust through direct peer contact, case studies, and clinical proof points. In markets where buying cycles are long, a strong conference presence can lift credibility faster than ads alone.
- Reaches key payer and provider buyers
- Supports value-based care credibility
- Shows specialty and population health expertise
Evolent Health promotes through direct enterprise sales, thought leadership, and investor communications. Its 2024 revenue was about $2.5 billion, so proof of outcomes matters more than broad ads. Conference talks and case studies help win payer and provider trust.
| Channel | Role | Key proof |
|---|---|---|
| Direct sales | Close large contracts | 2024 revenue about $2.5 billion |
| Thought leadership | Build trust | Value-based care insight |
| Investor updates | Shape market view | 2025 earnings and filings |
Price
Evolent Health, Inc. uses contract-based pricing, so fees are negotiated with enterprise clients rather than posted publicly. The price changes with scope, member volume, and service complexity, which fits its large-scale value-based care model. This approach helps align revenue with the size of each health plan contract and the level of clinical and administrative support delivered.
Evolent Health, Inc. likely prices its service fee structure around administrative and clinical support programs, with charges varying by client size, scope, and setup needs. This fits healthcare outsourcing, where fees often scale with implementation work and care-management complexity. The model matters because Evolent served 3.4 million members in 2024, so small fee changes can move revenue fast.
Evolent Health, Inc. prices its services around value-based care, so fees can rise when outcomes and total cost of care improve. That fits client goals because U.S. health spending hit $4.9 trillion in 2023, making even small efficiency gains material. The model links price to measurable results, not just activity.
No retail price tag
Evolent Health does not use a retail price tag. It sells enterprise care-management and value-based care solutions to healthcare payers and providers, so pricing is customized, contract-based, and kept confidential.
That model fits its scale: Evolent Health served 75+ health plan and provider clients in recent reporting, so fees vary by scope, members covered, and service mix.
- Custom pricing, not list pricing
- Buyer: payers and providers
- Terms vary by contract size
Enterprise-scale economics
Evolent Health, Inc. sells enterprise-scale care management, so price has to cover analytics, technology, clinical staff, and rollout support. Its model fits big health plans and providers, where multi-year contracts can turn into recurring fees and steadier cash flow. In 2024, Evolent reported $2.54 billion in revenue, which shows the scale needed for this kind of pricing.
- Built for large healthcare systems
- Price reflects tech and clinicians
- Multi-year deals support repeat revenue
- Scale matters more than list price
Evolent Health, Inc. uses contract pricing, so fees are set by deal terms, not a public list. Price moves with member volume, service scope, and care complexity, which suits its enterprise payers and providers. In 2024, Evolent Health reported $2.54 billion in revenue and served 3.4 million members.
| Price driver | What it means |
|---|---|
| Contract-based | Custom client pricing |
| Member volume | Scales with covered lives |
| Service scope | Depends on care mix |
| 2024 scale | $2.54B revenue; 3.4M members |
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.
